Lack of MG53 in human heart precludes utility as a biomarker of myocardial injury or endogenous cardioprotective factor
Frances A. Lemckert*, Adam Bournazos, Daniel M. Eckert, Manuel Kenzler, Joanne M. Hawkes, Tanya L. Butler, Bradley Ceely, Kathryn N. North, David S. Winlaw, Jonathan R. Egan, Sandra T. Cooper
Dive into the research topics of 'Lack of MG53 in human heart precludes utility as a biomarker of myocardial injury or endogenous cardioprotective factor'. Together they form a unique fingerprint.